Prostate cancer test spots men most at risk of death
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Prostate cancer test spots men most at risk of death" is generating significant coverage in the Health category, with 8 articles from 8 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Medical Xpress, News-Medical, Clinical Lab Products and Healthcare Management Magazine. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 22d ago.
Quick answers
Why is "Prostate cancer test spots men most at risk of death" trending?
Because 8 independent news sources published 8 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (8)
- Diagnostic test could help doctors refine prostate cancer treatment Medical Xpress · 25d ago
- Decipher tissue-based molecular test helps personalize high-risk prostate cancer treatment News-Medical · 25d ago
- Genomic Test Predicts Which Prostate Cancer Patients Benefit From Abiraterone Therapy Clinical Lab Products · 25d ago
- New hope for personalised prostate cancer treatment Healthcare Management Magazine · 25d ago
- Decipher test predicts which high-risk prostate cancer patients benefit from adding abiraterone to treatment. Pluang · 25d ago
- Prostate cancer DNA test could spare men unnecessary chemotherapy, according to a new study Daily Mirror · 25d ago
- Researchers will present first evidence that a prostate test predicts who benefits from an added drug. Stock Titan · 25d ago
- Prostate cancer test spots men most at risk of death The Telegraph · 25d ago
Topics
Related trends
Prostate cancer cases rose 2,000 in year after Chris Hoy’s diagnosis
Cancer diagnoses in England reached record levels exceeding one thousand daily cases, accompanied by a notable rise in prostate cancer figures.
8 Foods To Eat for Better Prostate Health
Health outlets and regional news outlets highlight prostate cancer awareness, early screenings, and dietary recommendations.
Prostate Cancer: Cases Rising 3% Annually as Experts Urge Screening
Prostate cancer cases are rising by 3% annually, prompting health experts to urge men to prioritize early screening during September awareness month.
Prostate cancer treatment with fewer side effects 'as effective as radiotherapy and surgery'
Focal therapy matches radiotherapy and surgery for prostate cancer while drastically cutting side effects.
New Israeli ultrasound procedure offers hope for enlarged prostate
A new Israeli ultrasound procedure and advanced technologies offer fresh hope for patients suffering from enlarged prostates.
Scientists May Have Discovered Why Men's Prostates Enlarge With Age
13 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.